Med LifeBSE:M 91 Current Ratio is 0.80 as of Mar. 2026, which is 3% above its 10-year median of 0.78. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.82 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Med Life ranks worse than 80.44% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Med Life's current ratio for the quarter that ended in Mar. 2026 was 0.80.
Med Life has a current ratio of 0.80. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Med Life has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Med Life's Current Ratio or its related term are showing as below:
BSE:M'
s Current Ratio Range Over the Past 10 Years
Min: 0.57 Med: 0.78 Max: 1.03
Current: 0.8
During the past 11 years, Med Life's highest Current Ratio was 1.03. The lowest was 0.57. And the median was 0.78.
BSE:M's Current Ratio is ranked worse than 80.44% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs BSE:M: 0.80
Med Life (BSE:M) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Med Life Current Ratio Related Terms
Med Life Current Ratio Historical Data
* Premium members only.
The historical data trend for Med Life's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Med Life's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Current Ratio distribution charts can be found below:
* The bar in red indicates where Med Life's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (BSE:M) has a Current Ratio of 0.80 as of Mar. 2026. This is near median its historical median of 0.78. Over the past decade, Med Life's Current Ratio has ranged from 0.57 to 1.03. According to the industry distribution chart, Med Life ranks #547 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 80.4%.
Is Med Life's Current Ratio too high?
Med Life's current Current Ratio of 0.80 is near median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 1.03. The Healthcare Providers & Services industry median Current Ratio is 1.47. Med Life's value of 0.80 is 45.6% below this industry median. Based on the distribution chart, Med Life ranks #547 out of 680 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Med Life has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #547 out of 680 companies for Current Ratio. This places Med Life in the lower half of its industry. The industry median Current Ratio is 1.47. Med Life's value of 0.80 is 45.6% below this benchmark. Historically, Med Life's own Current Ratio has ranged from 0.57 to 1.03 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 1.47, Med Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Current Ratio of 0.80 is 45.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Current Ratio is 0.80, which is near median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.82, compared to a current price of lei11.40 — trading 45.8% above its estimated fair value. The current Current Ratio is 0.80, which is near median its 10-year median of 0.78 and 45.6% below the Healthcare Providers & Services industry median of 1.47. Med Life's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Med Life (BSE:M), the current Current Ratio is 0.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (BSE:M) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.40 is trading 45.8% above its estimated GF Value™ of lei7.82.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
Current Ratio: 0.80 (near median its 10-year median of 0.78)
GF Value™: lei7.82 vs. price of lei11.40 (45.8% above fair value)
Industry Position: 45.6% below the Healthcare Providers & Services median (#547 of 680)
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score
Get the complete analysis for BSE:M
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:M has been successfully added to your 
